Opko CP-4

Enroll Now

Type of Study:

Growth hormone study for Pre-pubertal children with growth hormone deficiency

Title of Study:

Study Comparing the efficacy and safety of weekly MOD-4023 compared to daily Genotropin therapy in pre-pubertal children with growth hormone deficiency

Short Title:

MOD-4023

Study Length: 52 Weeks

Target Age/Sex: boys 3-11 girls 3 – 10 diagnosed with growth hormone deficiency

Benefits:

Participants will receive at no cost: study medication and study related supplies, study related lab work and study related exams.

Link: ClinicalTrials.gov